Clinical overview of irbesartan: A new angiotensin II receptor antagonist

American Journal of Hypertension

Volumn 10, Issue 12 II SUPPL., 1997, Pages

  Pouleur, Hubert G ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Angiotensin II receptor antagonist; Dose response; Drug; Hypertension; Irbesartan; Randomized controlled trials

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; ENALAPRIL; HYDROCHLOROTHIAZIDE; IRBESARTAN; PLACEBO;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; COUGHING; DEPRESSION; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FATIGUE; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; NAUSEA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEXUAL DYSFUNCTION; VERTIGO;

EID: 0031427277     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00386-5     Document Type: Article

References (10)

1. 1 subtype angiotensin II receptor antagonist. J Pharmacol Exp Ther. 265:1993;826-834.
2. Necciari J, Denolle T, Le Coz F, et al. Pharmacokinetics of SR 47436 (BMS 186295), a new angiotensin II receptor antagonist in man (abst). J Hypertens. 12:1994;88.
3. Ribstein J, Sissmann J, Picard A, et al. Effects of the angiotensin II antagonist SR 47436 (BMS 186295) on the pressor response to exogenous angiotensin II and the renin-angiotensin system in sodium replete normal subjects (abst). J Hypertens. 12:1994;131.
4. Fogari R, Ambrosoli S, Corradi L, et al: 24-Hour blood pressure control by once-daily irbesartan as assessed by monitoring ambulatory blood pressure. J Hypertens (in press).
5. Mimran A, Ruilope L, Kerwin L, et al. Comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of hypertension (abstract). J Hypertens. 15:(suppl 4):1997;S117.
6. Larochelle P, Flack JM, Hannah S, et al. Irbesartan versus enalapril in severe hypertension (abst). Am J Hypertens. 10:(4, part 2):1997;131A.
7. Stumpe KO, Haworth D, Höglund C, et al: Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertension. Blood Pressure (in press).
8. Pohl M, Cooper M, Ulrey J, et al. Safety and efficacy of irbesartan in hypertensive patients with type II diabetes and proteinuria (abst). Am J Hypertens. 10:(4, part 2):1997;105A.
9. Kochar M, Zablocki CJ, Guthrie R, et al. Irbesartan in combination with hydrochlorothiazide in mild-to-moderate hypertension (abst). Am J Hypertens. 10:(4, part 2):1997;106A.
10. Pool JL, Guthrie RM, Littlejohn TW III, et al: Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension (abst). Am J Hypertens (in press).